Skip Navigation



Rheumatology Advance Access published online on July 11, 2006

Rheumatology, doi:10.1093/rheumatology/kel205
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
46/2/215    most recent
kel205v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vázquez-Mellado, J.
Right arrow Articles by Burgos-Vargas, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vázquez-Mellado, J.
Right arrow Articles by Burgos-Vargas, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received November 28, 2005
Accepted May 12, 2006

Original Papers

Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout

J. Vázquez-Mellado 1 *, A. L. Jiménez-Vaca 2, S. Cuevas-Covarrubias 3, V. Alvarado-Romano 4, G. Pozo-Molina 5, and R. Burgos-Vargas 1

1 Rheumatology Service, Hospital General de México, Mexico; Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico
2 Hematology Service, Hospital General de México, Mexico
3 Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico; Department of Genetics, Hospital General de México, Mexico
4 Rheumatology Service, Hospital General de México, Mexico
5 Department of Molecular Biology and Genetics, Centro de Investigación y Estudios Avanzados (CINVESTAV), Instituto Politécnico Nacional, Mexico

* To whom correspondence should be addressed.
J. Vázquez-Mellado, E-mail: jvazquezmellado{at}prodigy.net.mx


   Abstract

Objective. To analyse the SLC22A12 (URAT1) gene in primary gout patients, first-grade relatives and healthy controls and the possible association of them with demographic and clinical data.

Subjects and Methods. We included 69 consecutive patients with diagnosis of primary gout, as well as 29 first-grade relatives and 120 healthy volunteers. Demographic and clinical data were obtained from the patients and relatives. DNA was purified from peripheral blood and all 10 exons of the SLC22A12 (URAT1) gene were sequenced.

Results. We found six different mutations in the SLC22A12 gene in 16 out of 69 (23%) patients with primary gout. Five mutations were in exon 5 and one in exon 4; five out of six mutations were heterozygous (one compound heterozygous) and one homozygous. The C850G mutation (exon 5) was found in 11 gout patients, these patients have lower levels of triglycerides than the rest of the group: 160 ± 56 vs 292 ± 203 mg/dl (P = 0.038). In one family, we found SLC22A12 mutations in three relatives within exon 5. We did not find mutations in the other exons studied (1-3 and 6-10), nor in any of the 10 exons of the 120 healthy volunteers.

Conclusions. We found several mutations in SLC22A12 gene associated with primary gout, the definite role of these mutations in URAT1 activity needs to be further studied.

Keywords: Gout; URAT1; Uric acid; SLC22A12.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
J Vazquez-Mellado, V Alvarado-Romano, R Burgos-Vargas, A L Jimenez-Vaca, G Pozo-Molina, and S A Cuevas-Covarrubias
Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid
J. Clin. Pathol., August 1, 2007; 60(8): 947 - 948.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.